Yes, the status of RB can significantly influence cancer treatment strategies. For instance, RB-deficient tumors may be more sensitive to certain chemotherapeutic agents that target the DNA replication machinery. Conversely, RB-positive tumors might respond better to treatments aimed at restoring RB function or enhancing its tumor-suppressive activities. Understanding the RB status of a tumor can thus inform tailored therapeutic approaches.